Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients.
Gokmen A, Sahin U, Soydan E, Gokgoz Z, Okcu MK, Ozan U, Arslan O, Ilhan O, Ozcan M. Gokmen A, et al. Among authors: ozan u. Clin Lymphoma Myeloma Leuk. 2022 Oct;22(10):e885-e892. doi: 10.1016/j.clml.2022.06.015. Epub 2022 Jul 1. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35927182
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience.
Çekdemir D, Güvenç S, Özdemirkıran F, Eser A, Toptaş T, Özkocaman V, Haydaroğlu Şahin H, Ermiş Turak E, Esen R, Cömert M, Sadri S, Aslaner M, Uncu Ulu B, Karakuş A, Selim Bapur D, Alacacıoğlu İ, Aydın D, Tekinalp A, Namdaroğlu S, Ceran F, Tarkun P, Kiper D, Çetiner M, Yenerel M, Demir AM, Yılmaz G, Terzi H, Atilla E, Malkan ÜY, Acar K, Öztürk E, Tombak A, Sunu C, Salim O, Alayvaz N, Sayan Ö, Ozan Ü, Ayer M, Gökgöz Z, Andıç N, Kızılkılıç E, Noyan F, Özen M, Pepedil Tanrıkulu F, Alanoğlu G, Özkan HA, Aslan V, Çetin G, Akyol Erikçi A, Deveci B, Ersoy Dursun F, Dermenci H, Aytan P, Gündüz M, Karakuş V, Özlü C, Demircioğlu S, Akay Yanar OM, Özatlı D, Ündar L, Tiftik EN, Türköz Sucak AG, Haznedaroğlu İ, Özcan M, Şencan M, Tombuloğlu M, Özet G, Bilgir O, Turgut B, Özcan MA, Payzın KB, Sönmez M, Ayyıldız O, Dal MS, Ertop Ş, Turgut M, Soysal T, Kaya E, Ünal A, Pehlivan M, Atagündüz I, Tuğlular Fıratlı T, Saydam G, Diz Küçükkaya R. Çekdemir D, et al. Among authors: ozan u. Turk J Haematol. 2019 Nov 18;36(4):230-237. doi: 10.4274/tjh.galenos.2019.2018.0307. Epub 2019 Jul 22. Turk J Haematol. 2019. PMID: 31327186 Free PMC article.
Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
Ali R, Ozkalemkaş F, Ozçelik T, Ozkocaman V, Ozan U, Kimya Y, Köksal N, Gülten T, Yakut T, Tunali A. Ali R, et al. Among authors: ozan u. Leuk Res. 2005 Aug;29(8):971-3. doi: 10.1016/j.leukres.2005.01.009. Epub 2005 Feb 16. Leuk Res. 2005. PMID: 15978950
Primary non-Hodgkin's T-cell lymphoma of bone.
Ali R, Ozkalemkaş F, Ozçelik T, Ozan U, Ozkocaman V, Tunali A. Ali R, et al. Among authors: ozan u. Leuk Lymphoma. 2004 Aug;45(8):1719-20. doi: 10.1080/10428190410001683778. Leuk Lymphoma. 2004. PMID: 15370235 No abstract available.
Tumour lysis syndrome with acute renal failure during imatinib therapy.
Ali R, Ozkalemkas F, Ozkan A, Ozcelik T, Ozkocaman V, Akdag I, Ozan U, Tunali A. Ali R, et al. Among authors: ozan u. Leuk Res. 2007 Apr;31(4):573-4. doi: 10.1016/j.leukres.2006.05.005. Epub 2006 Jun 16. Leuk Res. 2007. PMID: 16782190 No abstract available.
24 results